Top 10 Amlodipine (Norvasc) Generic Manufacturers in India

User avatar placeholder
Written by Robert Gultig

6 January 2026

Introduction:

The pharmaceutical industry in India has been experiencing significant growth in recent years, with a focus on producing high-quality generic medications at competitive prices. Amlodipine, commonly sold under the brand name Norvasc, is a popular medication used to treat high blood pressure and chest pain. In India, there are several manufacturers producing generic versions of Amlodipine. According to recent data, the market for Amlodipine generics in India is estimated to be worth over $100 million.

Top 10 Amlodipine (Norvasc) Generic Manufacturers in India:

1. Sun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries Ltd. is one of the largest pharmaceutical companies in India, with a strong presence in the generic drug market. They are a leading manufacturer of Amlodipine generics, with a production volume of over 10 million units per year.

2. Cipla Ltd.
Cipla Ltd. is another major player in the Indian pharmaceutical industry, known for its high-quality generic medications. They have a significant market share in the Amlodipine generics market, with exports to over 50 countries worldwide.

3. Lupin Limited
Lupin Limited is a pharmaceutical company that specializes in producing generic medications for various therapeutic areas. They have a strong presence in the Amlodipine generics market, with a trade value of over $20 million annually.

4. Dr. Reddy’s Laboratories Ltd.
Dr. Reddy’s Laboratories Ltd. is a global pharmaceutical company that is known for its research and development capabilities. They have a competitive edge in the Amlodipine generics market, with a market share of over 15%.

5. Torrent Pharmaceuticals Ltd.
Torrent Pharmaceuticals Ltd. is a leading player in the Indian pharmaceutical industry, with a focus on producing high-quality generic medications. They have a production volume of over 5 million units of Amlodipine generics per year.

6. Alembic Pharmaceuticals Ltd.
Alembic Pharmaceuticals Ltd. is a vertically integrated pharmaceutical company that is known for its state-of-the-art manufacturing facilities. They have a strong presence in the Amlodipine generics market, with exports to over 30 countries worldwide.

7. Glenmark Pharmaceuticals Ltd.
Glenmark Pharmaceuticals Ltd. is a research-driven pharmaceutical company that is known for its innovative products. They have a significant market share in the Amlodipine generics market, with a trade value of over $15 million annually.

8. Aurobindo Pharma Ltd.
Aurobindo Pharma Ltd. is a vertically integrated pharmaceutical company that is known for its focus on research and development. They have a production volume of over 7 million units of Amlodipine generics per year.

9. Intas Pharmaceuticals Ltd.
Intas Pharmaceuticals Ltd. is a global pharmaceutical company that is known for its high-quality generics. They have a competitive edge in the Amlodipine generics market, with a market share of over 10%.

10. Zydus Cadila
Zydus Cadila is a research-driven pharmaceutical company that is known for its focus on innovation and quality. They have a strong presence in the Amlodipine generics market, with exports to over 40 countries worldwide.

Insights:

The market for Amlodipine generics in India is expected to continue growing in the coming years, driven by factors such as the increasing prevalence of hypertension and cardiovascular diseases. With a focus on producing high-quality medications at competitive prices, Indian pharmaceutical companies are well-positioned to capitalize on this growing market. According to industry forecasts, the market for Amlodipine generics in India is projected to reach a value of over $150 million by 2025, with key players like Sun Pharmaceutical Industries Ltd. and Cipla Ltd. leading the way. As competition in the market intensifies, companies will need to continue investing in research and development to maintain their competitive edge and meet the growing demand for Amlodipine generics.

Related Analysis: View Previous Industry Report

Author: Robert Gultig in conjunction with ESS Research Team

Robert Gultig is a veteran Managing Director and International Trade Consultant with over 20 years of experience in global trading and market research. Robert leverages his deep industry knowledge and strategic marketing background (BBA) to provide authoritative market insights in conjunction with the ESS Research Team. If you would like to contribute articles or insights, please join our team by emailing support@essfeed.com.
View Robert’s LinkedIn Profile →